Preexisting TCR Clones in HNSCC Patients Treated with Dual Immune Checkpoint Inhibitors

A supplemental table from a 2026 research publication on head and neck squamous cell carcinoma. The dataset likely contains differentially expressed genes associated with T-cell receptor super clones, comparing non-responder patients post-treatment versus baseline. Authored by Huaibin Ge and shared under a CC-BY-4.0 license.

Use Cases

• Identify gene expression signatures associated with T-cell receptor super clones based on the description.
• Compare transcriptional profiles between baseline and post-treatment timepoints in non-responder patients.
• Investigate potential biomarkers for resistance to dual immune checkpoint inhibitor therapy in HNSCC.

Strengths

• Dataset is small (4.1 KB), facilitating quick download and initial inspection.
• Shared under a permissive CC-BY-4.0 license, allowing for broad reuse.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Freshness

Last updated 2026-06-01 07:24:58.